VKT PHARMA
GenericsVKT PHARMA is a generic drug manufacturer focused on Gastroenterology, Cardiovascular.
VKT PHARMA's Key Drugs
VKT PHARMA's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
VKT PHARMA's Recent FDA Approvals
VKT PHARMA secured 1 new FDA approval for novel drugs (NDA/BLA) in the last two years.
VKT PHARMA's Therapeutic Areas
VKT PHARMA's approved drugs and pipeline span 2 therapeutic areas, led by Gastroenterology and Cardiovascular. Weighted by commercial stage — approved drugs count most, then late-stage trials.
VKT PHARMA's Top Competitors
VKT PHARMA's closest competitors by therapeutic-area and drug-target overlap include BAUSCH, Takeda, and APOTHECON. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
VKT PHARMA Pipeline Snapshot
Active clinical trials for VKT PHARMA across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Gastroenterology pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2019-01-31
- Latest
- 2025-03-28
- Applications
- 6